Average Co-Inventor Count = 2.57
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (2 from 3,681 patents)
2. Genomic Health, Inc. (2 from 59 patents)
3. Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 14 patents)
4. Sigma-tau Farmaceutiche Riunite, S.p.a. (1 from 3 patents)
5. Instituto Nazionale Tumori (1 from 1 patent)
6. Policlinico San Matteo, Istituto Di Ricovero E Cura a Carattere (1 from 1 patent)
7. Sigma-tau Industrie Farmaceutiche Riunite S.p.a. (343 patents)
8. F. Hoffmann-la Roche Ag (168 patents)
9. Fondazione Irccs Istituto Nazionale Dei Tumori (9 patents)
6 patents:
1. 9605318 - Gene expression markers for predicting response to chemotherapy
2. 7871769 - Gene expression markers for predicting response to chemotherapy
3. 7700613 - Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
4. 6927211 - Method for reducing toxicity of combined chemotherapies
5. 6906040 - Method for reducing toxicity of combined chemotherapies
6. 5637572 - Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis